{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,7,6]],"date-time":"2025-07-06T04:01:27Z","timestamp":1751774487933,"version":"3.41.0"},"reference-count":43,"publisher":"Japan Neurosurgical Society","issue":"0","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,12,31]]},"DOI":"10.2176\/jns-nmc.2024-0335","type":"journal-article","created":{"date-parts":[[2025,6,29]],"date-time":"2025-06-29T22:09:33Z","timestamp":1751234973000},"page":"275-281","source":"Crossref","is-referenced-by-count":0,"title":["Difficulties of Differentiating Primary Histiocytic Sarcoma of the Central Nervous System from Glioblastoma in Older Patients: Methylation Analysis and Review of the Literature"],"prefix":"10.2176","volume":"12","author":[{"given":"Ryota","family":"TAOMOTO","sequence":"first","affiliation":[{"name":"Department of Pathology, Fukuoka University of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mikiko","family":"AOKI","sequence":"additional","affiliation":[{"name":"Department of Pathology, Fukuoka University of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Toshiyuki","family":"ENOMOTO","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, Fukuoka University of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Noriko","family":"HIRAO","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, Fukuoka University of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroshi","family":"ABE","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, Fukuoka University of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Junji","family":"SHIBAHARA","sequence":"additional","affiliation":[{"name":"Department of Pathology, Faculty of Medicine, Kyorin University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Koichi","family":"ICHIMURA","sequence":"additional","affiliation":[{"name":"Department of Pathology, Faculty of Medicine, Kyorin University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kaishi","family":"SATOMI","sequence":"additional","affiliation":[{"name":"Department of Pathology, Faculty of Medicine, Kyorin University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Makoto","family":"HAMASAKI","sequence":"additional","affiliation":[{"name":"Department of Pathology, Fukuoka University of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"971","reference":[{"key":"1","doi-asserted-by":"publisher","unstructured":"1) Louis DN, Perry A, Wesseling P, et al. The 2021 WHO Classification of Tumors of the central nervous system: a summary. Neuro Oncol. 2021;23 (8):1231-51. doi: 10.1093\/neuonc\/noab106","DOI":"10.1093\/neuonc\/noab106"},{"key":"2","doi-asserted-by":"publisher","unstructured":"2) Torres CF, Korones DN, Powers JM, et al. Primary leptomeningeal histiocytic lymphoma in a young child. Med Pediatr Oncol. 1996;27 (6):547-50. doi: 10.1002\/(SICI)1096-911X(199612)27:6&lt;547::AID-MPO7&gt;3.0.CO;2-L","DOI":"10.1002\/(SICI)1096-911X(199612)27:6<547::AID-MPO7>3.0.CO;2-L"},{"key":"3","doi-asserted-by":"publisher","unstructured":"3) Cheuk W, Walford N, Lou J, et al. Primary histiocytic lymphoma of the central nervous system: a neoplasm frequently overshadowed by a prominent inflammatory component. Am J Surg Pathol. 2001;25 (11):1372-9. doi: 10.1097\/00000478-200111000-00004","DOI":"10.1097\/00000478-200111000-00004"},{"key":"4","doi-asserted-by":"publisher","unstructured":"4) Sun W, Nordberg ML, Fowler MR. Histiocytic sarcoma involving the central nervous system: clinical, immunohistochemical, and molecular genetic studies of a case with review of the literature. Am J Surg Pathol. 2003;27 (2):258-65. doi: 10.1097\/00000478-200302000-00017","DOI":"10.1097\/00000478-200302000-00017"},{"key":"5","doi-asserted-by":"publisher","unstructured":"5) Cao M, Eshoa C, Schultz C, et al. Primary central nervous system histiocytic sarcoma with relapse to mediastinum: a case report and review of the literature. Arch Pathol Lab Med. 2007;131 (2):301-5. doi: 10.5858\/2007-131-301-PCNSHS","DOI":"10.5858\/2007-131-301-PCNSHS"},{"key":"6","doi-asserted-by":"publisher","unstructured":"6) Orsey A, Paessler M, Lange BJ, et al. Central nervous system juvenile xanthogranuloma with malignant transformation. Pediatr Blood Cancer. 2008;50 (4):927-30. doi: 10.1002\/pbc.21252","DOI":"10.1002\/pbc.21252"},{"key":"7","doi-asserted-by":"publisher","unstructured":"7) Toshkezi G, Edalat F, O&apos;Hara C, et al. Primary intramedullary histiocytic sarcoma. World Neurosurg. 2010;74 (4-5):523-7. doi: 10.1016\/j.wneu.2010.07.002","DOI":"10.1016\/j.wneu.2010.07.002"},{"key":"8","doi-asserted-by":"publisher","unstructured":"8) Gill-Samra S, Ng T, Dexter M, et al. Histiocytic sarcoma of the brain. J Clin Neurosci. 2012;19 (10):1456-8. doi: 10.1016\/j.jocn.2011.10.023","DOI":"10.1016\/j.jocn.2011.10.023"},{"key":"9","doi-asserted-by":"publisher","unstructured":"9) Gomi K, Tanaka M, Yoshida M, et al. Primary cerebellar histiocytic sarcoma in a 17-month-old girl. J Neurosurg Pediatr. 2012;10 (2):126-9. doi: 10.3171\/2012.5.PEDS11270","DOI":"10.3171\/2012.5.PEDS11270"},{"key":"10","doi-asserted-by":"publisher","unstructured":"10) Bell SL, Hanzely Z, Alakandy LM, et al. Primary meningeal histiocytic sarcoma: a report of two unusual cases. Neuropathol Appl Neurobiol. 2012;38 (1):111-4. doi: 10.1111\/j.1365-2990.2011.01205.x","DOI":"10.1111\/j.1365-2990.2011.01205.x"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11) Devic P, Androdias-Condemine G, Streichenberger N, et al. Histiocytic sarcoma of the central nervous system: a challenging diagnosis. Qjm. 2012;105 (1):77-9. doi: 10.1093\/qjmed\/hcq244","DOI":"10.1093\/qjmed\/hcq244"},{"key":"12","doi-asserted-by":"publisher","unstructured":"12) Wang J, Li T, Chen H, et al. A case of primary central nervous system histiocytic sarcoma. Clin Neurol Neurosurg. 2012;114 (7):1074-6. doi: 10.1016\/j.clineuro.2012.02.009","DOI":"10.1016\/j.clineuro.2012.02.009"},{"key":"13","doi-asserted-by":"publisher","unstructured":"13) Wu W, Tanrivermis Sayit AT, Vinters HV, et al. Primary central nervous system histiocytic sarcoma presenting as a postradiation sarcoma: case report and literature review. Hum Pathol. 2013;44 (6):1177-83. doi: 10.1016\/j.humpath.2012.11.002","DOI":"10.1016\/j.humpath.2012.11.002"},{"key":"14","doi-asserted-by":"publisher","unstructured":"14) Almefty RO, Tyree TL, Fusco DJ, et al. Primary histiocytic sarcoma of the brain mimicking cerebral abscess. J Neurosurg Pediatr. 2013;12 (3):251-7. doi: 10.3171\/2013.6.PEDS12533","DOI":"10.3171\/2013.6.PEDS12533"},{"key":"15","doi-asserted-by":"publisher","unstructured":"15) Chalasani S, Hennick MR, Hocking WG, et al. Unusual presentation of a rare cancer: histiocytic sarcoma in the brain 16 years after treatment for acute lymphoblastic leukemia. Clin Med Res. 2013;11 (1):31-5. doi: 10.3121\/cmr.2012.1092","DOI":"10.3121\/cmr.2012.1092"},{"key":"16","doi-asserted-by":"publisher","unstructured":"16) Laviv Y, Zagzag D, Fichman-Horn S, et al. Primary central nervous system histiocytic sarcoma. Brain Tumor Pathol. 2013;30 (3):192-5. doi: 10.1007\/s10014-012-0123-z","DOI":"10.1007\/s10014-012-0123-z"},{"key":"17","doi-asserted-by":"publisher","unstructured":"17) P\u00e9rez-Ruiz E, Delgado M, Sanz A, et al. Primary leptomeningeal histiocytic sarcoma in a patient with a good outcome: a case report and review of the literature. J Med Case Rep. 2013;7:127. doi: 10.1186\/1752-1947-7-127","DOI":"10.1186\/1752-1947-7-127"},{"key":"18","doi-asserted-by":"publisher","unstructured":"18) Bai J, Li G, Shen M, et al. Primary central nervous system histiocytic sarcoma mimicking glioma. Neurol India. 2014;62 (6):684-5. doi: 10.4103\/0028-3886.149409","DOI":"10.4103\/0028-3886.149409"},{"key":"19","doi-asserted-by":"publisher","unstructured":"19) Idbaih A, Mokhtari K, Emile JF, et al. Dramatic response of a BRAF V600E-mutated primary CNS histiocytic sarcoma to vemurafenib. Neurology. 2014;83 (16):1478-80. doi: 10.1212\/WNL.0000000000000880","DOI":"10.1212\/WNL.0000000000000880"},{"key":"20","doi-asserted-by":"publisher","unstructured":"20) Moulignier A, Mikol J, Heran F, et al. Isolated III cranial nerve palsies may point to primary histiocytic sarcoma. BMJ Case Rep. 2014;2014:bcr2014204663. doi: 10.1136\/bcr-2014-204663","DOI":"10.1136\/bcr-2014-204663"},{"key":"21","doi-asserted-by":"publisher","unstructured":"21) Nieuwenhuis MB, van der Salm SM, Verhoeff JJ, et al. A 43-year-old female with multifocal cerebral lesions. Histiocytic sarcoma. Brain Pathol. 2015;25 (3):371-2. doi: 10.1111\/bpa.12260","DOI":"10.1111\/bpa.12260"},{"key":"22","doi-asserted-by":"publisher","unstructured":"22) Brown AF, Fan H, Floyd JR, et al. Primary central nervous system histiocytic sarcoma arising after precursor B-cell acute lymphoblastic leukemia. J Neuropathol Exp Neurol. 2015;74 (12):1120-6. doi: 10.1097\/NEN.0000000000000258","DOI":"10.1097\/NEN.0000000000000258"},{"key":"23","doi-asserted-by":"publisher","unstructured":"23) Chen CJ, Williams EA, McAneney TE, et al. Histiocytic sarcoma of the cavernous sinus: case report and literature review. Brain Tumor Pathol. 2015;32 (1):66-71. doi: 10.1007\/s10014-014-0191-3","DOI":"10.1007\/s10014-014-0191-3"},{"key":"24","doi-asserted-by":"publisher","unstructured":"24) Foster M, Kamaly-Asl I, Stivaros S, et al. Primary cerebral histiocytic sarcoma in childhood: a case report of protracted survival and review of the literature. Childs Nerv Syst. 2015;31 (12):2363-8. doi: 10.1007\/s00381-015-2815-2","DOI":"10.1007\/s00381-015-2815-2"},{"key":"25","doi-asserted-by":"publisher","unstructured":"25) So H, Kim SA, Yoon DH, et al. Primary histiocytic sarcoma of the central nervous system. Cancer Res Treat. 2015;47 (2):322-8. doi: 10.4143\/crt.2013.163","DOI":"10.4143\/crt.2013.163"},{"key":"26","doi-asserted-by":"publisher","unstructured":"26) Curry RC, Faivre G, Akkari L, et al. High-dose methotrexate-based chemotherapy as treatment for histiocytic sarcoma of the central nervous system. Leuk Lymphoma. 2016;57 (8):1961-4. doi: 10.3109\/10428194.2015.1120867","DOI":"10.3109\/10428194.2015.1120867"},{"key":"27","doi-asserted-by":"publisher","unstructured":"27) Ueno T, Nishijima H, Kurotaki H, et al. An unusual case of chronic meningitis due to histiocytic sarcoma of the central nervous system with meningeal dissemination. Neurol Sci. 2016;37 (11):1875-7. doi: 10.1007\/s10072-016-2636-4","DOI":"10.1007\/s10072-016-2636-4"},{"key":"28","doi-asserted-by":"publisher","unstructured":"28) Clifton W, Akinduro OO, Lopez-Chiriboga S, et al. Infection or glioma? the false dilemma of primary central nervous system histiocytic sarcoma. World Neurosurg. 2017;106:1053.e1-5. doi: 10.1016\/j.wneu.2017.07.001","DOI":"10.1016\/j.wneu.2017.07.001"},{"key":"29","doi-asserted-by":"crossref","unstructured":"29) Kim YH, Yie GT, Kim NR, et al. Pediatric intracerebral histiocytic sarcoma with rhabdoid features: case report and literature review. Neuropathology. 2017;37 (6):560-8. doi: 10.1111\/neup.12396","DOI":"10.1111\/neup.12396"},{"key":"30","doi-asserted-by":"publisher","unstructured":"30) Zanelli M, Ragazzi M, Marchetti G, et al. Primary histiocytic sarcoma presenting as diffuse leptomeningeal disease: case description and review of the literature. Neuropathology. 2017;37 (6):517-25. doi: 10.1111\/neup.12390","DOI":"10.1111\/neup.12390"},{"key":"31","doi-asserted-by":"publisher","unstructured":"31) May JM, Waddle MR, Miller DH, et al. Primary histiocytic sarcoma of the central nervous system: a case report with platelet derived growth factor receptor mutation and PD-L1\/PD-L2 expression and literature review. Radiat Oncol. 2018;13 (1):167. doi: 10.1186\/s13014-018-1115-x","DOI":"10.1186\/s13014-018-1115-x"},{"key":"32","doi-asserted-by":"publisher","unstructured":"32) Takahashi E, Sakakibara A, Tsuzuki T, et al. Case of primary central nervous system histiocytic sarcoma with prominent proliferation of histiocytic cells between the trabeculae of reactive glial cells. Neuropathology. 2018;38 (6):609-18. doi: 10.1111\/neup.12510","DOI":"10.1111\/neup.12510"},{"key":"33","doi-asserted-by":"publisher","unstructured":"33) Marguet F, Piton N, Adle-Biassette H, et al. Molecular characteristics of multifocal brain histiocytic sarcoma. Neuropathol Appl Neurobiol. 2019;45 (3):309-13. doi: 10.1111\/nan.12490","DOI":"10.1111\/nan.12490"},{"key":"34","doi-asserted-by":"publisher","unstructured":"34) Rajeshwari M, Suri V, Sarkar C, et al. Primary histiocytic sarcoma of brain-illustration of two cases with varied histomorphological features. Neurol India. 2022;70 (3):1254-9. doi: 10.4103\/0028-3886.349657","DOI":"10.4103\/0028-3886.349657"},{"key":"35","doi-asserted-by":"publisher","unstructured":"35) Rogawski DS, Nirschl JJ, McDonald J, et al. A rare neuromyelitis optica mimic: primary CNS histiocytic sarcoma. Mult Scler. 2022;28 (10):1651-4. doi: 10.1177\/13524585221097564","DOI":"10.1177\/13524585221097564"},{"key":"36","doi-asserted-by":"publisher","unstructured":"36) Shahrokh S, Rakhsha A, Shahin M, et al. Successful treatment of central nervous system histiocytic sarcoma with craniectomy and adjuvant radiotherapy. Cureus. 2022;14 (5):e24690. doi: 10.7759\/cureus.24690","DOI":"10.7759\/cureus.24690"},{"key":"37","doi-asserted-by":"publisher","unstructured":"37) Negishi K, Ishihara M, Adachi S, et al. Primary histiocytic sarcoma of the central nervous system: a case report. Interdiscip Neurosurg. 2022;28 (6):101522. doi: 10.1016\/j.inat.2022.101522","DOI":"10.1016\/j.inat.2022.101522"},{"key":"38","doi-asserted-by":"publisher","unstructured":"38) Cecchi R, Guptil D, Haslett N, et al. Primary CNS histiocytic sarcoma: two case reports highlighting a novel MIGA2::BRAF gene fusion and genome-wide DNA methylation profiling results. J Neuropathol Exp Neurol. 2024;83 (10):882-6. doi: 10.1093\/jnen\/nlae061","DOI":"10.1093\/jnen\/nlae061"},{"key":"39","doi-asserted-by":"publisher","unstructured":"39) Shanmugam V, Griffin GK, Jacobsen ED, et al. Identification of diverse activating mutations of the RAS-MAPK pathway in histiocytic sarcoma. Mod Pathol. 2019;32 (6):830-43. doi: 10.1038\/s41379-018-0200-x","DOI":"10.1038\/s41379-018-0200-x"},{"key":"40","doi-asserted-by":"publisher","unstructured":"40) Massoth LR, Hung YP, Ferry JA, et al. Histiocytic and dendritic cell sarcomas of hematopoietic origin share targetable genomic alterations distinct from follicular dendritic cell sarcoma. Oncologist. 2021;26 (7):e1263-72. doi: 10.1002\/onco.13801","DOI":"10.1002\/onco.13801"},{"key":"41","doi-asserted-by":"publisher","unstructured":"41) Abe E, Suzuki M, Ichimura K, et al. Implications of DNA methylation classification in diagnosing ependymoma. World Neurosurg. 2024;185:e1019-29. doi: 10.1016\/j.wneu.2024.03.013","DOI":"10.1016\/j.wneu.2024.03.013"},{"key":"42","doi-asserted-by":"publisher","unstructured":"42) Sasame J, Ikegaya N, Kawazu M, et al. HSP90 inhibition overcomes resistance to molecular targeted therapy in BRAFV600E-mutant high-grade glioma. Clin Cancer Res. 2022;28 (11):2425-39. doi: 10.1158\/1078-0432.CCR-21-3622","DOI":"10.1158\/1078-0432.CCR-21-3622"},{"key":"43","doi-asserted-by":"publisher","unstructured":"43) Fujimoto K, Arita H, Satomi K, et al. TERT promoter mutation status is necessary and sufficient to diagnose IDH-wildtype diffuse astrocytic glioma with molecular features of glioblastoma. Acta Neuropathol. 2021;142 (2):323-38. doi: 10.1007\/s00401-021-02337-9","DOI":"10.1007\/s00401-021-02337-9"}],"container-title":["NMC Case Report Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/nmccrj\/12\/0\/12_2024-0335\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,5]],"date-time":"2025-07-05T04:55:50Z","timestamp":1751691350000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/nmccrj\/12\/0\/12_2024-0335\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,31]]},"references-count":43,"journal-issue":{"issue":"0","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.2176\/jns-nmc.2024-0335","relation":{},"ISSN":["2188-4226"],"issn-type":[{"type":"electronic","value":"2188-4226"}],"subject":[],"published":{"date-parts":[[2025,12,31]]},"article-number":"2024-0335"}}